Robin Hohsfield
YOU?
Author Swipe
View article: Transitions between infused and oral prostacyclin pathway agents in pulmonary arterial hypertension: key considerations
Transitions between infused and oral prostacyclin pathway agents in pulmonary arterial hypertension: key considerations Open
Prostacyclin pathway agents are a critical treatment for patients with pulmonary arterial hypertension. Seven prostacyclin pathway agents are available, including agents administered by parenteral infusion, by inhalation, and orally. Pulmo…
View article: Pulmonary Arterial Hypertension Emergency Complications and Evaluation
Pulmonary Arterial Hypertension Emergency Complications and Evaluation Open
Pulmonary hypertension (PH) complicates common diseases and can lead to worsening symptoms and increased mortality. A specific group of PH, pulmonary arterial hypertension (PAH), World Health Organization Group 1, may present to the emerge…
View article: Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension
Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension Open
Therapies that target the prostacyclin pathway are considered effective, yet are complex to dose and may cause dose‐limiting side effects for patients with pulmonary arterial hypertension (PAH). Careful side effect management and the abili…